Table 2.
Variable | Level | Odds ratio | Lower bound | Upper bound |
---|---|---|---|---|
VOC | Alpha | ref | ||
Delta | 0.99 | 0.83 | 1.17 | |
Omicron | 1.13 | 0.96 | 1.33 | |
transit | 1.17* | 1.00 | 1.36 | |
Age group | [00,06) | 0.33* | 0.32 | 0.35 |
[06,18) | 0.74* | 0.73 | 0.75 | |
[18,25) | 0.93* | 0.92 | 0.95 | |
[25,45) | ref | |||
[45,65) | 1.12* | 1.11 | 1.14 | |
[65, Inf) | 1.31* | 1.28 | 1.33 | |
Sex | F | ref | ||
M | 0.98* | 0.97 | 0.99 | |
Disease stage | Asymptomatic | ref | ||
Presymptomatic | 1 | 0.94 | 1.05 | |
Symptomatic | 2.29* | 2.25 | 2.32 | |
Late Symptomatic | 0.64* | 0.61 | 0.69 | |
Unknown | 1.08* | 1.06 | 1.10 |
Coefficients on immunity status and dominant VOC were included in the Supplementary Table S2 (VOC, Variant of Concern, Age group in years; F, Female; M, Male, * = 1 outside of the 95% CI), Belgium, 29 March 2021–22 February 2022.